Filter by

EMCDDA Document Library

This EMCDDA Document library give you access to a wide variety of documents related to the agency, or used by it in its work including: publications by international and national organisations, scientific articles by EMCDDA staff, material published by other institutions of the European Union, source material used by the agency when analysing the drug situation in Europe.

Note: if you are looking for publications by the EMCDDA, please see our Publications database.

Displaying 1 - 10 of 1097
Document library

Justice and Home Affairs Agencies Network (JHAAN) - Final report 2023

The Justice and Home Affairs Agencies Network (JHAAN) - Final report 2023 describes de the key achievements of the network. These are achieved through regular meetings at horizontal level and through several...
Nitazenes represent a growing threat to public health in Europe
Document library

Letter to the Lancet Public Health editors. Nitazenes represent a growing threat to public health in Europe

This correspondence, co-authored by a number of EMCDDA staff on the subject of the growing health threat of nitazenes was published in the Lancet Public Health journal.
Document library

Minutes of the 58th meeting of the EMCDDA Scientific Committee

Minutes of the 58th meeting of the EMCDDA Scientific Committee
Document library

General Drug Policy Unit (2023) Belgium’s interfederal strategy for a global and integrated drug policy 2024-25

This 2023 document by the General Drug Policy Unit presents Belgium’s interfederal strategy for a global and integrated drug policy 2024-25.
Document library

Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis

Epidemiological data are crucial to monitoring progress towards the 2030 Hepatitis C Virus (HCV) elimination targets. The aim was to estimate the prevalence of chronic HCV infection (cHCV) in the European Union...
Document library

Formal opinion of the Scientific Committee on the EMCDDA 2024–26 single programming document, including the 2024 work programme

Formal opinion of the Scientific Committee on the EMCDDA 2024–26 single programming document
Document library

Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review

Background People who inject drugs are disproportionately affected by HIV and hepatitis C virus (HCV) infections, while there is little global data on HIV and HCV testing and treatment coverage of this...
Document library

Guidelines on the appointment of seconded national experts at the EMCDDA

This document provides guidelines to the members of selection panels to help them carry out their tasks during selection procedures for seconded national experts (SNEs) at the EMCDDA and to the potential...
Document library

Agenda and minutes of the 67th EMCDDA Management Board meeting (29 June 2023)

Agenda and minutes of the 67th EMCDDA Management Board meeting (29 June 2023)
Document library

Identifying the impact of the business cycle on drug-related harms in European countries

The evidence resulting from the analysis of the association between economic fluctuations and their impact on the substance use is mixed and inconclusive. Effects can be pro-cyclical (drug-related harms are predicted to...
Top